Non-Covid respiratory illnesses on rise in UK, medical experts say
Increase in cases of bronchitis and common colds attributed to people mixing after easing of lockdownCoronavirus – latest updatesSee all our coronavirus coverageNon-Covid respiratory illnesses and other conditions that were suppressed over the winter by lockdown are slowly “marching upwards” again, albeit at a level below what doctors expect for this time of year.The increase in conditions such as bronchitis and the common cold was attributed by an expert at the Royal College of General Practitioners (RCGP) to the onset of people mixing again amid the lifting of lockdown measures.Continue reading... (Sour...
Source: Guardian Unlimited Science - July 9, 2021 Category: Science Authors: Ben Quinn Tags: Infectious diseases Coronavirus Health Medical research UK news Hospitals England Source Type: news

Health Highlights: June 25, 2021
Here's HealthDay's top stories for Friday, June 25: Colds make a comeback. As rules on mask-wearing, social distancing and mass gatherings relax, there's a surge in colds, bronchitis and other respiratory ills in doctor's offices& ERs across... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 25, 2021 Category: General Medicine Source Type: news

Colds, Bronchitis Cases Resurged After Texas Eased COVID Rules
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 9, 2021 Category: Respiratory Medicine Tags: Infections, Pulmonology, Preventive Medicine, News, Source Type: news

Colds, Bronchitis Cases Resurged After Texas Eased COVID Rules
WEDNESDAY, June 9, 2021 -- After Texas relaxed COVID-19 restrictions, other respiratory illnesses -- such as colds, bronchitis and pneumonia -- made rapid rebounds. Pathologists from Houston Methodist Hospital found that the rhinovirus and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2021 Category: General Medicine Source Type: news

Colds, Bronchitis Cases Resurged After Texas Eased COVID Rules
Title: Colds, Bronchitis Cases Resurged After Texas Eased COVID RulesCategory: Health NewsCreated: 6/9/2021 12:00:00 AMLast Editorial Review: 6/9/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - June 9, 2021 Category: Respiratory Medicine Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Acute Bronchitis
Title: Acute BronchitisCategory: Diseases and ConditionsCreated: 9/2/2005 12:00:00 AMLast Editorial Review: 5/25/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 25, 2021 Category: Respiratory Medicine Source Type: news

Gala Therapeutics Announces First Patients Enrolled in Pivotal Trial of RheOx(TM) System for Chronic Bronchitis
SAN CARLOS, Calif., May 20, 2021 -- (Healthcare Sales & Marketing Network) -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, has initiated its pivotal clinical trial to evaluate its RheOx™ Bronchial Rheoplasty S... Devices Gala Therapeutics, RheOx, Bronchial Rheoplasty, bronchitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 20, 2021 Category: Pharmaceuticals Source Type: news

New Phase 3 Data Showed First-in-Class TREMFYA ® (guselkumab) Provided Durable Complete Skin Clearance Through Five Years in Moderate to Severe Plaque Psoriasis (PsO) and Robust Joint Symptom Improvement Through 52 Weeks in Active Psoriatic Arthritis (PsA)
SPRING HOUSE, PENNSYLVANIA, April 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new Phase 3 data which showed TREMFYA® (guselkumab) sustained durable, complete skin clearance rates in a majority of adults with moderate to severe plaque psoriasis (PsO) through five years (252 weeks), a and improved disease activity and axial symptoms in adults with active psoriatic arthritis (PsA) through one year (52 weeks).1,2,3 These data are being presented at the American Academy of Dermatology Virtual Meeting Experience 2021, where Janssen will present a total of 22 abstracts. TREMF...
Source: Johnson and Johnson - April 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

ACP Offers Guidance on Antibiotic Duration for Common Infections
Best practices recommend limiting antibiotics to five days for COPD exacerbations, acute uncomplicated bronchitis (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 21, 2021 Category: Respiratory Medicine Tags: Dermatology, Family Medicine, Gastroenterology, Gynecology, Infections, Internal Medicine, Emergency Medicine, Ophthalmology, ENT, Pharmacy, Pulmonology, Urology, Journal, Source Type: news

New Phase 3 Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Complete Skin Clearance and Favorable Joint Efficacy in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years
SPRING HOUSE, PENNSYLVANIA, March 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced long-term data from the Phase 3 DISCOVER-2a study showing that the skin clearance, joint symptom relief, and safety of TREMFYA® (guselkumab) previously demonstrated through 24 weeks and one year (Week 52) in adults with active psoriatic arthritis (PsA) continued through two years (Week 112).1,2 These findings also confirmed that the robust efficacy TREMFYA demonstrated in patients at Week 24 on physical function, physical aspects of health-related quality of life, and resolution of enthesitis...
Source: Johnson and Johnson - March 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Lung cancer symptoms: Bronchitis that won't go away is an early warning sign
LUNG cancer is one of the most common and serious types of cancer, with around 47,000 people diagnosed with the condition every year in the UK. Bronchitis that doesn't go away is an early warning sign. (Source: Daily Express - Health)
Source: Daily Express - Health - February 23, 2021 Category: Consumer Health News Source Type: news

How Do You Know if You Have Bronchitis or COVID-19 (Coronavirus)?
Title: How Do You Know if You Have Bronchitis or COVID-19 (Coronavirus)?Category: Diseases and ConditionsCreated: 2/17/2021 12:00:00 AMLast Editorial Review: 2/17/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 17, 2021 Category: Respiratory Medicine Source Type: news

What Is the Best Medicine and Treatment for Bronchitis?
Title: What Is the Best Medicine and Treatment for Bronchitis?Category: Diseases and ConditionsCreated: 2/16/2021 12:00:00 AMLast Editorial Review: 2/16/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 16, 2021 Category: Respiratory Medicine Source Type: news

Acute Bronchitis Contagoius Symptoms, Causes, Treatment, and Recovery Time
Title: Acute Bronchitis Contagoius Symptoms, Causes, Treatment, and Recovery TimeCategory: Diseases and ConditionsCreated: 9/2/2005 12:00:00 AMLast Editorial Review: 2/9/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 9, 2021 Category: Respiratory Medicine Source Type: news

How Do You Know If Your Child Has Bronchitis?
Title: How Do You Know If Your Child Has Bronchitis?Category: Diseases and ConditionsCreated: 1/21/2021 12:00:00 AMLast Editorial Review: 1/21/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 21, 2021 Category: Respiratory Medicine Source Type: news

Is Bronchitis Contagious Through Kissing?
Title: Is Bronchitis Contagious Through Kissing?Category: Diseases and ConditionsCreated: 1/8/2021 12:00:00 AMLast Editorial Review: 1/8/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 8, 2021 Category: Respiratory Medicine Source Type: news

What Is the Treatment for Asthmatic Bronchitis?
Title: What Is the Treatment for Asthmatic Bronchitis?Category: Diseases and ConditionsCreated: 12/21/2020 12:00:00 AMLast Editorial Review: 12/21/2020 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - December 21, 2020 Category: Respiratory Medicine Source Type: news

How Do You Know if Your Baby has Bronchitis?
Title: How Do You Know if Your Baby has Bronchitis?Category: Diseases and ConditionsCreated: 12/16/2020 12:00:00 AMLast Editorial Review: 12/16/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - December 16, 2020 Category: Respiratory Medicine Source Type: news

What Are the Main Causes of Bronchitis?
Title: What Are the Main Causes of Bronchitis?Category: Diseases and ConditionsCreated: 12/15/2020 12:00:00 AMLast Editorial Review: 12/15/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - December 15, 2020 Category: Respiratory Medicine Source Type: news

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
             Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dos...
Source: Roche Media News - November 24, 2020 Category: Pharmaceuticals Source Type: news

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
             Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dos...
Source: Roche Investor Update - November 24, 2020 Category: Pharmaceuticals Source Type: news

E-cigarette users have 30% higher risk for chronic lung diseases, study finds
E-cigarette users have a roughly 30% higher risk for developing respiratory illness, such as chronic obstructive pulmonary disease, emphysema, chronic bronchitis and asthma than non-users, according to a study in JAMA. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 12, 2020 Category: Consumer Health News Source Type: news

CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
This study will provide a scientific rationale for the remodeling response and clinical improvements identified in the feasibility study BOSTON, Nov. 11, 2020 -- (Healthcare Sales & Marketing Network) -- CSA Medical, Inc., today announced that over hal... Devices CSA Medical, cryotherapy, RejuvenAir, COPD, Bronchitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 11, 2020 Category: Pharmaceuticals Source Type: news

New source of lymphatic system leak discovered in children with rare open heart surgery complication
(Nemours) Interventional radiologists with Nemours Children's Health System have identified a new source of abnormal lymphatic flow between the liver and the lungs that may be responsible for some cases of plastic bronchitis. Plastic bronchitis is a rare but serious late complication in patients with congenital heart disease who had Fontan surgery. A report detailing the discovery of this fluid leak, and successful treatment of two cases was published in European Heart Journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 11, 2020 Category: International Medicine & Public Health Source Type: news

CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
The SPRAY-CB trial marks the first pivotal study of a medical device therapy targeting the underlying cause of Chronic Bronchitis BOSTON, Oct. 22, 2020 -- (Healthcare Sales & Marketing Network) -- CSA Medical Inc., a developer of medical devices advanc... Devices CSA Medical, cryotherapy, RejuvenAir System, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 22, 2020 Category: Pharmaceuticals Source Type: news

Temple treats 1st patient in trial of RejuvenAir Metered Cryospray System for COPD with CB
(Temple University Health System) Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir ® System for the treatment of patients suffering from moderate to severe COPD with chronic bronchitis. Chronic bronchitis is characterized by a productive cough for months or years. Dr. Gerard Criner, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine and Director of the Temple Lung Center, is the overall principal investigator. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2020 Category: International Medicine & Public Health Source Type: news

Bronchitis in Early Childhood Linked to Later Lung Disease
Lung diseases occurring later in life more likely to be asthma, pneumonia rather than chronic bronchitis (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 2, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Allergy, Pediatrics, Pulmonology, Conference News, Source Type: news

Bronchitis in Early Childhood Linked to Later Lung Disease
THURSDAY, Oct. 1 2020 -- Children who have bronchitis at least once before the age of 7 years are more likely to develop lung problems in later life, according to a study presented at the European Respiratory Society International Congress 2020,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news

SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Glo...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news

What Helps When You Have Bronchitis?
Title: What Helps When You Have Bronchitis?Category: Diseases and ConditionsCreated: 9/29/2020 12:00:00 AMLast Editorial Review: 9/29/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 29, 2020 Category: Respiratory Medicine Source Type: news

Donor-conceived adults have higher incidence of immunology diseases
(Flinders University) Adults conceived through sperm donation reported higher frequencies of allergies, type 1 diabetes and other autoimmune conditions. Donor sperm conceived adults had seven times more type 1 diabetes diagnoses; double the incidence of thyroid disease, acute bronchitis and sleep apnoea; and 10% more reported allergies. The study looked at 272 donor-conceived adult participants compared to 877 conceived naturally, from around the world with most from Australia, US, UK, Belgium and Netherlands. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 23, 2020 Category: Biology Source Type: news

Bronchitis in Childhood Tied to Worse Lung Health in Adulthood Bronchitis in Childhood Tied to Worse Lung Health in Adulthood
Children who suffer a bout of bronchitis at least once before their seventh birthday are at increased risk for developing lung problems such as asthma and pneumonia later in life, a study suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 14, 2020 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Bronchitis can be treated with a 'flash-freeze' icy blast to the lungs in new 30 minute procedure
The RejuvenAir procedure is being offered as part of a trial at the Royal Brompton & Harefield NHS Foundation Trust and the Chelsea & Westminster Hospital NHS Foundation Trust. (Source: the Mail online | Health)
Source: the Mail online | Health - August 15, 2020 Category: Consumer Health News Source Type: news

Covid lockdown: England sees fewer cases of colds, flu, and bronchitis, BMJ
Figures published by the Royal College of General Practitioners, derived from data from 500 practices across England, suggest that lockdown and physical distancing measures to prevent the spread of covid-19 were the probable cause of the trend. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 13, 2020 Category: Consumer Health News Source Type: news

Cold, flu and bronchitis infections fell 'well below average' during coronavirus lockdown
A report by the Royal College of GPs shows rates for these viruses fell drastically when the UK locked down in late March. Ten times fewer were going to their GP with a cold last month. (Source: the Mail online | Health)
Source: the Mail online | Health - August 10, 2020 Category: Consumer Health News Source Type: news

TREMFYA ® (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] TREMFYA is the first treatment approved for active PsA that selectively inhibits interleukin (IL)-23, a naturally occurring cytokine that is involved in normal inflammatory and immune responses associated with the symptoms of PsA. The safety and efficacy of TREMFYA in PsA have b...
Source: Johnson and Johnson - July 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Follow-up appointments for children hospitalized for bronchiolitis may not be needed
(Intermountain Medical Center) A new study at Intermountain Primary Children's Hospital in Salt Lake City has found that follow-up appointments for hospitalized children treated for childhood bronchitis are often not necessary, and that switching from mandatory to 'as-needed' follow-up care can save families from unnecessary medical care and expense - and may help guide treatment during the COVID-19 pandemic. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news

Children ’ s Robitussin And Dimetapp Cough Medicines Recalled For Potential Overdose Risks
(CNN) — Parents take note: GlaxoSmithKline Consumer Healthcare has voluntarily recalled three lots of its children’s cough syrups — Children’s Robitussin Honey Cough and Chest Congestion DM and Children’s Dimetapp Cold and Cough — due to the products having incorrect dosing cups in their packaging. That means parents might accidentally overdose a child by putting too much syrup in the cup. Symptoms of overdose of either product may include impaired coordination, elevated blood pressure, dizziness, seizure, nausea, vomiting, constipation, diarrhea, abdominal pain, hallucinations, among ot...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 19, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News CNN Cough Syrup Recall Source Type: news

Subcutaneous Daratumumab Combination Resulted in Deep and Rapid Hematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, NJ, June 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomized Phase 3 study investigating subcutaneous daratumumab[i] in the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare and potentially fatal disease.[1],[2] The data demonstrated subcutaneous daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (D-CyBorD) resulted in a higher hematologic complete response rate (CR), (53 percent vs. 18 percent [P
Source: Johnson and Johnson - June 15, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Inherent Flaws in COVID-19 Testing Mean Some of Those Infected Don ’t Get the Treatment They Need
In late February, several weeks before the coronavirus outbreak shut down American cities and rose to the level of a national crisis, Kerri Rawson began to feel sick. “I was hit out of nowhere with what feels like the flu at first,” says Rawson, who also has asthma and takes cardiac medication for high-blood pressure. “You’re fine, and then all of a sudden you have a fever below 100°F and chest congestion.” Rawson is a 41-year-old writer and mother of two in Florida. (You may recognize her name from her 2019 memoir, about growing up as the daughter of a serial killer.) Her fever lasted for...
Source: TIME: Health - May 8, 2020 Category: Consumer Health News Authors: Zach Schonfeld Tags: Uncategorized COVID-19 feature Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Smoking Marijuana Even Occasionally Raises Risk Of Coronavirus Complications, Experts Say
(CNN) — If you’re smoking weed to ease your stress during the coronavirus pandemic, experts say it’s time to think twice. Smoking marijuana, even occasionally, can increase your risk for more severe complications from Covid-19, the disease caused by the novel coronavirus. “What happens to your airways when you smoke cannabis is that it causes some degree of inflammation, very similar to bronchitis, very similar to the type of inflammation that cigarette smoking can cause,” said pulmonologist Dr. Albert Rizzo, chief medical officer for the American Lung Association. “Now you have some air...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 10, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Coronavirus Marijuana Source Type: news

Coronavirus Recovery Story: Marshfield Man Beats Severe COVID-19 Case
MARSHFIELD (CBS) – Across the United States, more than 24,000 people have recovered from coronavirus. One of them is a South Shore man who just left the hospital after a serious fight against the virus. Curtis Akins is back home in Marshfield now, but the 55-year-old is still tethered to an oxygen tank. Just a couple weeks ago, he wasn’t sure he would ever see his home again. “The first 3 or 4 days I’d say were the scariest moments of my life,” he said. Medical staff cheered Curtis Akins as he was released from South Shore Hospital, and he cheered them right back. (Image courtesy of South Shor...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 9, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Bill Shields Coronavirus South Shore Hospital Source Type: news

Understanding end-stage COPD: Coping strategies for patients and their loved ones
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a cluster of potentially fatal respiratory conditions. It is marked by breathlessness, inflammation, airway obstruction and significant bronchial damage. Many of the chronic respiratory diseases classified under COPD, such as emphysema and chronic bronchitis, are primarily caused by exposure to cigarette smoke. However, COPD can also... (Source: NaturalNews.com)
Source: NaturalNews.com - March 30, 2020 Category: Consumer Health News Source Type: news

Similarities and differences between emphysema and chronic bronchitis, two conditions that fall under COPD
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a group of life-threatening diseases that severely affect the lungs, causing breathlessness, inflammation, airway obstruction and significant bronchial damage over time. Many of the chronic respiratory diseases classified under COPD are primarily caused by exposure to tobacco smoke, but they can also be exacerbated by factors such as air quality, existing cardiovascular... (Source: NaturalNews.com)
Source: NaturalNews.com - March 24, 2020 Category: Consumer Health News Source Type: news

Coronavirus: Debunking Myths And Misinformation
(CNN) — As the novel coronavirus — and panic about the coronavirus — continues to spread around the world, so too are bogus claims, conspiracy theories and misinformation about the disease. There’s so much inaccurate information floating around out there that the World Health Organization is calling it an “infodemic.” In perhaps the clearest sign of the times, WHO has joined TikTok to help set the record straight. Read: Coronavirus – What You Should And Shouldn’t Do The myths exist both on the fringes of the internet and in more mainstream outlets. And while social media...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 4, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health CNN Coronavirus Source Type: news

The 4 stages of COPD: Pay attention to your symptoms and make lifestyle changes to prevent it
(Natural News) COPD, or chronic obstructive pulmonary disease, is an umbrella term referring to a group of progressive lung diseases. Among the common diseases classified under COPD are emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, only behind cancer and heart disease.... (Source: NaturalNews.com)
Source: NaturalNews.com - February 27, 2020 Category: Consumer Health News Source Type: news

Raspberries: A potential treatment for COPD?
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a group of progressive lung diseases, including common ones like emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, behind cancer and heart disease. More than 15.3 million Americans have been diagnosed with COPD,... (Source: NaturalNews.com)
Source: NaturalNews.com - February 24, 2020 Category: Consumer Health News Source Type: news

Common Antibiotics Linked To Increased Risk Of Birth Defects, Study Says
(CNN) — Taking some common antibiotics during the first trimester of pregnancy was linked with higher risk of birth defects, according to a new study. The study, published Wednesday in the medical journal BMJ, found an increased risk of birth defects in the children of women who were prescribed macrolides during the first three months of pregnancy compared to mothers who were prescribed penicillin. Macrolide antibiotics include erythromycin, clarithromycin and azithromycin, and they are used to treat infections, such as pneumonia, bronchitis and urinary, skin and sexually transmitted diseases. They are often prescrib...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 20, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Source Type: news